RS4665765

Biomarker

1 paper mentions it2 findings

See all 1 papers on RS4665765

“identify a new genome-wide significant risk locus for pan-AML at 2p23.3 (rs4665765; P = 1.35 × 10-8; EFR3B, POMC, DNMT3A, and DNAJC27)”
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemiaBlood2026doi:10.1182/blood.2025031266

Associations

2

Mortality

mixedin humans1

1 study
  1. RS4665765 is associated with mortality in humans (AML patients) (P = 6.09 × 10-3).

    “which also significantly associates with patient survival (P = 6.09 × 10-3).”

    HumansAML patients

    Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia

    Blood

Acute myeloid leukemia

upin humans1

1 study
  1. RS4665765 is linked with a higher risk of acute myeloid leukemia in humans (P = 1.35 × 10-8).

    “identify a new genome-wide significant risk locus for pan-AML at 2p23.3 (rs4665765; P = 1.35 × 10-8; EFR3B, POMC, DNMT3A, and DNAJC27)”

    Humans

    Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia

    Blood

More on Acute myeloid leukemia

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months